Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland

2004904 citationsJournal Articlebronze Open Access

Authors

Margot Mütsch · University of Zurich

Weigong Zhou · National Center for Immunization and Respiratory Diseases

Philip Rhodes · National Center for Immunization and Respiratory Diseases

Matthias Bopp · University of Zurich

Robert T. Chen · National Center for Immunization and Respiratory Diseases

Thomas Linder · Luzerner Kantonsspital

Christian Spyr

Abstract

This study suggests a strong association between the inactivated intranasal influenza vaccine used in Switzerland and Bell's palsy. This vaccine is no longer in clinical use.

Topics & Keywords

Facial Nerve Paralysis Treatment and Research Infectious Diseases and Tuberculosis Head and Neck Surgical Oncology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 350, Issue 9, pp. 896-903

DOI: 10.1056/nejmoa030595

Field-Weighted Citation Impact: 27.69